Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis.

Mar 14, 2014Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

Comparing pioglitazone, quercetin, and hydroxy citric acid on fat damage and antioxidant levels in a model of fatty liver inflammation

AI simplified

Abstract

Levels of lipid peroxidation products, malondialdehyde (MDA), were significantly increased in experimentally induced NASH compared to the control group.

  • Experimental NASH rats treated with pioglitazone, quercetin, and hydroxy citric acid showed significant reduction in MDA levels.
  • Non-enzymatic antioxidant glutathione (GSH) and various antioxidant enzymes were significantly decreased in experimental NASH compared to the control group.
  • Treatment with pioglitazone resulted in marked increases in GSH, catalase, and superoxide dismutase (SOD) levels.
  • Hydroxy citric acid treatment led to marked increases in GSH and catalase levels but did not significantly affect SOD, glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione-S-transferase (GST) levels.
  • Quercetin treatment significantly increased levels of GSH, catalase, SOD, GPx, GR, and GST compared to the NASH induced group.
  • The antioxidant properties of quercetin may be more beneficial in the treatment of NASH than those of pioglitazone and hydroxy citric acid.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free